ICU infections demand precise antimicrobial strategies to reduce mortality risk.
Critically ill patients are at high risk for mortality due to infections compounded by antimicrobial resistance and altered pharmacokinetics. Effective antimicrobial management depends on microbiologic diagnostics, patient-specific factors, and local resistance patterns. Understanding pharmacokinetics in critically ill patients is key in selecting and dosing antimicrobials appropriately. Highlights the importance of tailored therapy in ICU settings. Balancing early appropriate therapy with resistance and toxicity risk is vital in the ICU.
📊 Deep Analysis Available
Subscribers get the full breakdown: study design, outcomes, pharmacist implications, clinical pearls, GRADE evidence grade, and a downloadable PDF report. Cancel anytime.
Free account, no credit card. Includes 1 full deep analysis every month.
Authors:Gillett EM, Dube KM, Rhee C
Citation:Gillett EM, Dube KM, Rhee C Antibiotic Considerations in the Critically Ill: Empiric Choices and Dosing. Critical care clinics. 2026;42(3):585-609. doi:10.1016/j.ccc.2026.01.003